
Alporate D 500mg Tablet ER
Marketer
Alteus Biogenics Pvt Ltd
Salt Composition
Divalproex (500mg)
Overview Alporate D 500mg Tablet ER
Epileptic seizures and migraine prevention are key uses for the extended-release Alporate D 500mg tablet. It's also occasionally prescribed for bipolar disorder management. Dosage and frequency are determined individually by your physician to optimize symptom control. Administer with or without food, consistently at the same time daily for maximum effectiveness; therapeutic benefits typically appear within a couple of weeks. Continuous, prescribed use is crucial; discontinuation or missed doses can exacerbate the condition and potentially trigger seizures. Gradual cessation under medical supervision is essential. Common, usually mild, side effects include headache, nausea, vomiting, dizziness, fatigue, vertigo, bruising, and hypothermia. Report persistent or bothersome side effects to your doctor promptly. Seek immediate medical attention for skin rashes or redness. Prolonged use may increase osteoporosis risk and fracture probability, and rarely, may precipitate suicidal ideation or behavior; report any mood changes to your physician immediately. Prior to commencing treatment, inform your doctor about any pre-existing heart, kidney, or liver conditions, urinary difficulties, depression, or suicidal tendencies. Potential drug interactions exist; provide a comprehensive list of your current medications to ensure safety. Consult your doctor before starting or stopping Alporate D during pregnancy. Alcohol consumption should be avoided due to increased side effect and seizure risk. Regular blood tests are often required to monitor dosage efficacy both prior to and during treatment.
Primary Ingredients of Alporate D 500mg Tablet ER
No text provided to rephrase.
Uses of Alporate D 500mg Tablet ER
Managing epileptic seizures and bipolar disorder; migraine prevention.
Major Benefits of Alporate D 500mg Tablet ER:
Follow your doctor's instructions precisely regarding the dosage and treatment length for this medication. Ingest the 500mg Alporate D Extended-Release tablet whole; avoid chewing, crushing, or breaking it. While Alporate D 500mg Tablet ER can be taken with or without food, consistent timing is recommended.
Common Side effects of Alporate D 500mg Tablet ER:
- Decreased body temperature
- Dizziness
- Sleepiness
- Tremors
- Paresthesia (tingling or pricking sensation)
- Anemia (low number of red blood cells)
- Decreased sodium level in blood
- Liver injury
- Gastrointestinal disturbance
- Hypersensitivity
- Deafness
- Urinary incontinence
- Increase in body weight
- Pain during periods
How to use Alporate D 500mg Tablet ER:
Follow your doctor's instructions precisely regarding dosage and treatment length for Alporate D 500mg Extended-Release Tablets. Ingest the tablets whole; avoid chewing, crushing, or breaking them. While Alporate D 500mg ER can be taken with or without food, consistent timing is recommended.
How Alporate D 500mg Tablet ER works:
Epileptic seizures are managed by Alporate D 500mg Extended-Release tablets, an anticonvulsant that reduces heightened, irregular neuronal firing in the brain.
SAFETY ADVICE
AlcoholUNSAFE
Consuming alcohol concurrently with Alporate D 500mg Extended-Release tablets can lead to significant sleepiness.
PregnancyCONSULT YOUR DOCTOR
Extended-release Alporate D 500mg tablets pose a confirmed risk to fetal development and should not be taken during pregnancy. In exceptional, life-threatening circumstances, a physician might prescribe it if the potential benefits outweigh the known hazards. Physician consultation is advised.
Breast feedingSAFE IF PRESCRIBED
Extended-release Alporate D 500mg tablets are considered safe for breastfeeding mothers. Research in humans indicates minimal drug transfer to breast milk, posing no apparent risk to the infant.
DrivingUNSAFE
Extended-release Alporate D 500mg tablets may impair driving ability due to potential adverse reactions.
KidneySAFE IF PRESCRIBED
Extended-release Alporate D 500mg tablets are considered safe for use in individuals with renal impairment. No alteration of the Alporate D 500mg extended-release tablet dosage is necessary.
LiverUNSAFE
Extended-release Alporate D 500mg tablets are contraindicated for individuals with hepatic impairment and should be omitted. Seek medical advice.
What if you forget to take Alporate D 500mg Tablet ER :
Should you forget a dose of Alporate D 500mg Extended-Release Tablet, administer it immediately upon remembrance. If, however, your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Alporate D 500mg Tablet ER
| Label | Value |
|---|---|
| Chemical Type | Derivatives of Aliphatic Carboxylic Acids |
| Developing Habits | No. |
| Treatment Category | Neuroscience (CNS) |
| Actions | Anticonvulsant sodium channel blockers |
